H00300 | |
H number | H00300 |
Name | Enterobacter infection |
Description | Enterobacter infections are commonly found in nosocomial settings and Enterobacter spp. have been recognized as increasingly important pathogens. They are intrinsically resistant to aminopenicillins, cefazolin, and cefoxitin because they produce constitutive chromosome AmpC beta-lactamase. Enterobacter spp. are recovered from the respiratory tract, surgical wounds, urinary tract, and blood and are implicated in a broad range of clinical syndromes. |
Category | Bacterial infectious disease |
Network | - |
Gene | - |
Pathogen | Enterobacter cloacae [GN:enc eec ecls] Enterobacter hormaechei [GN:eclx ecly eclz ecla eclc] Cronobacter sakazakii [GN:esa csk csj] Cronobacter turicensis [GN:ctu] Enterobacter agglomerans |
Env factor | - |
Carcinogen | - |
Drug | - |
Comment | Approximately 31% of Enterobacter spp. infections in intensive care units in the United States involve strains not susceptible to third-generation cephalosporins. |
Other DBs | ICD-11: 1A1Y ICD-10: A04.8 |
Reference | PMID:9105752 AUTHORS Sanders WE Jr, Sanders CC TITLE Enterobacter spp.: pathogens poised to flourish at the turn of the century. JOURNAL Clin Microbiol Rev 10:220-41 (1997) DOI:10.1128/CMR.10.2.220-241.1997 PMID:16813978 AUTHORS Paterson DL TITLE Resistance in gram-negative bacteria: Enterobacteriaceae. JOURNAL Am J Infect Control 34:S20-8; discussion S64-73 (2006) DOI:10.1016/j.ajic.2006.05.238 |